Picture used for illustrative purpose.
The EQT X fund (EQT Private Equity), and Mubadala Investment Company (Mubadala), have agreed to acquire Envirotainer (the company), the leading global provider of mission-critical, proprietary temperature-controlled supply chain solutions for the transportation of biopharmaceuticals, from Cinven and Novo Holdings.
The enterprise value amounts to approximately €2.8 billion.
Millions of people across the globe depend on the safe delivery of biopharmaceuticals that require temperature control to maintain their integrity and quality. Today, lack of access to medicines is a cause of the distress that impacts underserved communities, whose situation is likely to be exacerbated by chronic diseases resulting from changing diets and lifestyles, and air and water pollution. Envirotainer expands access to vital pharmaceuticals and vaccines through its patient-safe, reliable and efficient cold chain solutions, which are the most climate-neutral offering in the industry.
EQT Private Equity and Mubadala will seek to support Envirotainer in its next growth phase by accelerating expansion in APAC and continuing stable growth in its other core markets. They will leverage EQT’s local-with-locals approach and Mubadala’s global network to do so. Both investors will help scale the newly launched CryoSure offering and continue the successful roll-out of third-generation Releye containers while investing in new technology innovations, digitalisation, and sustainability in its operations.